Sudden cardiac death in athletes: What sport-rehabilitation specialists need to know

被引:2
作者
Evans, CC [1 ]
Cassady, SL
机构
[1] Midwestern Univ, Phys Therapy Program, Downers Grove, IL 60515 USA
[2] St Ambrose Univ, Phys Therapy Dept, Davenport, IA 52803 USA
关键词
familial hypertrophic cardiomyopathy; cardiovascular screening;
D O I
10.1123/jsr.12.3.259
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To describe the underlying conditions that predispose athletes to sudden cardiac death (SCID) and review signs and symptoms that indicate an athlete is at risk. Data Sources: MEDLINE, the Los Angeles Times and Triathlon Times archives, and other sources identified in the references of articles initially located therein. A total of 43 references were included. Conclusions: Most cases of SCD in younger athletes (less than or equal to 35 years) are attributable to multiple hereditary conditions, with familial hypertrophic cardiomyopathy being the primary cause, whereas the major cause of SCD in older athletes (>35 years) is coronary artery disease. Health-care professionals evaluating athletes should pay particular attention to past medical and family history. Items in an athlete's screening that suggest increased risk include a history of chest pain, syncope, excessive shortness of breath, irregular heart rate or murmur, or a history of SCD in an immediate family member.
引用
收藏
页码:259 / 271
页数:13
相关论文
共 43 条
[1]   Clinical features of Wolff-Parkinson-White syndrome [J].
Al-Khatib, SM ;
Pritchett, ELC .
AMERICAN HEART JOURNAL, 1999, 138 (03) :403-413
[2]  
*AM AC FAM PHYS AM, 1996, PREP PHYS EV
[3]   Hypertrophic cardiomyopathy and sudden death in the young: Pathologic evidence of myocardial ischemia [J].
Basso, C ;
Thiene, G ;
Corrado, D ;
Buja, G ;
Melacini, P ;
Nava, A .
HUMAN PATHOLOGY, 2000, 31 (08) :988-998
[4]  
CARLSON T, 2002, INSIDE TRIATHLO 0212
[5]   HYPERTROPHIC CARDIOMYOPATHY - PATHOLOGY AND PATHOGENESIS [J].
DAVIES, MJ ;
MCKENNA, WJ .
HISTOPATHOLOGY, 1995, 26 (06) :493-500
[6]   Sudden cardiac death in young athletes - Causes, athlete's heart, and screening guidelines [J].
Drezner, JA .
POSTGRADUATE MEDICINE, 2000, 108 (05) :37-+
[7]   Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy [J].
Evans, CC ;
Pena, JR ;
Phillips, RM ;
Muthuchamy, M ;
Wieczorek, DF ;
Solaro, RJ ;
Wolska, BM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (05) :H2414-H2423
[8]   Primary prevention of sudden death with implantable defibrillator therapy in patients with cardiac disease - Can we afford to do it? (Can we afford not to?) [J].
Exner, DV ;
Klein, GJ ;
Prystowsky, EN .
CIRCULATION, 2001, 104 (13) :1564-1570
[9]   PREVALENCE OF HYPERTROPHIC CARDIOMYOPATHY AND LIMITATIONS OF SCREENING METHODS [J].
FANANAPAZIR, L ;
EPSTEIN, ND .
CIRCULATION, 1995, 92 (04) :700-704
[10]   Cardiovascular evaluation of the athlete - Issues regarding performance, screening and sudden cardiac death [J].
Franklin, BA ;
Fletcher, GF ;
Gordon, NF ;
Noakes, TD ;
Ades, PA ;
Balady, GJ .
SPORTS MEDICINE, 1997, 24 (02) :97-119